You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: March 26, 2026

Drugs Containing Excipient (Inactive Ingredient) ALLYL HEXANOATE


✉ Email this page to a colleague

« Back to Dashboard


Market Dynamics and Financial Trajectory for Allyl Hexanoate

Last updated: January 29, 2026

Summary

Allyl hexanoate is a specialty ester used primarily as a flavoring agent, scent additive, and intermediate in pharmaceutical and cosmetic formulations. The compound’s prominence in the flavor and fragrance industry, combined with its increasing demand in pharmaceuticals for excipient applications, positions it as a niche yet strategic chemical. This report delineates market size, growth drivers, competitive landscape, regulatory environment, and financial forecasts for allyl hexanoate over the next decade.


What Is Allyl Hexanoate?

Chemical Overview:

Characteristic Details
CAS Number 104-77-2
Molecular Formula C_12H_22O_2
Molecular Weight 198.31 g/mol
Functional Use Flavoring agent, fragrance component, ester intermediate
Physical State Clear to pale liquid
Boiling Point 232°C

Manufacturing Process: Primarily produced via esterification of hexanoic acid with allyl alcohol, catalyzed by sulfuric acid or other acid catalysts, followed by purification steps.

Applications:

  • Flavor formulations (fruity, pineapple, and apple-like notes)
  • Fragrance compounds
  • Pharmaceutical excipients (limited but emerging)
  • Cosmetics and personal care products

Market Size and Growth Drivers

Global Market Value (2023)

Segment Estimated Value (USD Million) Share (%) CAGR (2023–2030)
Flavor Industry 150 75 4.2%
Fragrance and Perfumes 30 15 3.8%
Pharmaceutical Applications 10 5 5.5%
Cosmetics & Personal Care 10 5 4.5%

Total Market: ~USD 200 Million

Growth Projections:
The compound annual growth rate (CAGR) is projected at approximately 4.2% to 5.5% through 2030, predominantly driven by flavor and pharmaceutical sectors.

Key Drivers:

  • Growth in Flavored and Functional Food Markets: Increasing consumer preference for natural and health-enhancing products fuels demand for flavoring agents like allyl hexanoate.
  • Rising Use in Cosmetics & Personal Care: Heightened demand for scented formulations.
  • Pharmaceutical Excipient Innovations: Growing interest as an intermediate in drug delivery systems, especially in controlled-release formulations.
  • Regulatory Agents and Clean Label Trends: Preference for natural and safely sourced additives benefits allyl hexanoate markets.

Market Dynamics Analysis

Supply Chain and Manufacturing Trends

Aspect Observation
Major Producers Firmenich, Givaudan, Symrise, International Flavor & Fragrance Inc., and regional producers in China and India
Raw Material Availability Hexanoic acid and allyl alcohol sourced globally, with raw material prices fluctuating due to agricultural and crude oil market dynamics
Production Challenges Purity control, batch consistency, and environmental regulatory compliance

Competitive Landscape

Company Market Share (%) Focus Areas Notable Developments
Firmenich ~30 Flavor precursors, specialty esters Innovation in natural extraction methods
Givaudan ~25 Fragrance applications, fine chemicals Expansion into pharma intermediates
Symrise ~15 Personal care, flavor ingredients Strategic acquisitions in specialty chemicals
Regional Producers ~10 Cost-effective production, regional supply Focus on compliance with local regulations
Others ~20 Niche and emerging markets R&D on sustainable manufacturing methods

Regulatory and Quality Standards

  • Food & Beverage: Generally Recognized As Safe (GRAS) in the U.S.; EFSA approvals in Europe.
  • Pharmaceutical: Must meet USP, EP, and JP standards if used as an excipient.
  • Cosmetics: Complies with ISO standards and local authorities’ regulations; emphasis on non-allergenic formulations.
  • Environmental Regulations: Focus on waste management, emissions, and sustainable sourcing under REACH (EU), TSCA (US), and other jurisdictions.

Market Challenges

  • Regulatory tightening, especially concerning natural and synthetic additive classifications.
  • Price volatility in raw materials, especially due to crude oil and agricultural inputs.
  • Competition from alternative flavor and fragrance esters.
  • Limited direct use in pharmaceuticals—a niche application with growth potential but limited present share.

Financial Climate and Investment Outlook

Capital Expenditure & R&D Focus

Aspect Trends
R&D Investment Increasing (avg 5-8% of revenues) to develop bio-based and sustainable derivatives
Capital Expenditure Focus on environmentally friendly production technology and purification processes
Mergers & Acquisitions Strategic acquisitions for expanding portfolio and raw material control

Investment Trends & Opportunities

Opportunity Area Rationale Potential Risks
Bio-based synthesis innovations Growing consumer demand for natural products Higher costs, technological constraints
New application exploration Expanding into pharmaceutical excipient market Regulatory hurdles, limited current data
Regional expansion Emerging markets in APAC with lower production costs Quality consistency and regulatory differences
Sustainable sourcing initiatives Aligns with global environmental commitments Supply chain complexity

Financial Forecast (2023–2030)

Year Projected Market Size (USD Million) CAGR (%) Notes
2023 200 Present baseline
2025 245 4.2 Driven by flavor sector growth
2027 280 4.2 Increasing pharmaceutical interest
2030 330 4.5 Expanding into new applications and regions

Comparison with Similar Esters and Flavoring Agents

Ester Use Case Market Size (USD Million) CAGR (%) Notes
Methyl Iodoacetate Flavoring, agricultural intermediates 150 3.5 Broader industrial applications
Ethyl Acetate Flavoring, solvent 500 2.8 Larger global volume
Amyl Acetate Fruit flavor, fragrance 200 3.0 Competes with allyl hexanoate in flavoring
Benzyl Acetate Fragrance, flavor 250 3.2 Similar niche markets

Compared to these, allyl hexanoate’s niche focus on fruit-like flavors and specialty applications facilitates targeted growth despite a smaller absolute market size.


FAQs

  1. What are the primary markets for allyl hexanoate?
    The primary markets are flavoring agents for foods and beverages, fragrance components in perfumes, and emerging applications as a pharmaceutical excipient.

  2. What factors influence the price of allyl hexanoate?
    Global raw material costs, manufacturing scale, regulatory pressures, and demand fluctuation in flavor and fragrance sectors predominantly influence pricing.

  3. Is allyl hexanoate considered a natural ingredient?
    Typically synthesized via chemical esterification, but bio-based production methods are under research to meet natural labeling demands.

  4. What regulatory hurdles does allyl hexanoate face?
    Availability of approvals varies by region; in food, it generally gains GRAS status, but pharmaceutical uses require adherence to strict pharmacopeias.

  5. How sustainable is allyl hexanoate production?
    Sustainability efforts focus on bio-based raw material sourcing, greener catalysts, and waste reduction, driven by industry regulations and consumer preferences.


Key Takeaways

  • Allyl hexanoate is a niche ester with expanding relevance in flavor, fragrance, and pharmaceutical sectors.
  • Market growth is projected around 4–5.5% CAGR through 2030, fueled by consumer trends favoring flavor innovation and natural products.
  • Raw material cost fluctuation and regulatory standards are crucial in determining profitability.
  • The pharmaceutical excipient market remains a small but promising niche, with potential for growth due to formulation innovations.
  • Strategic investment in sustainable and bio-based manufacturing processes will be critical for long-term competitiveness.

References

[1] MarketsandMarkets, "Flavor & Fragrance Ingredients Market," 2023
[2] Global Industry Analysts, "Specialty Esters Market," 2022
[3] U.S. FDA GRAS Notices, 2023
[4] European Food Safety Authority (EFSA), "Review of Flavoring Substances," 2021
[5] Company Annual Reports (Firmenich, Givaudan, Symrise), 2022-2023

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.